KAT6-IN-4
KAT6-IN-4 (Compound Example 2) is a selective lysine acetyltransferase 6 (KAT6) inhibitor. KAT6-IN-4 suppresses transcription of oncogenes like ERα. KAT6-IN-4 demonstrates potent antitumor efficacy in ER+/HER2- breast cancer xenografts. KAT6-IN-4 is promising for research of KAT6-driven malignancies (e.g., breast cancer, NSCLC) [1].
Product Specifications
CAS Number
2901797-38-2
UNSPSC
12352005
Target
Estrogen Receptor/ERR; Histone Acetyltransferase
Related Pathways
Epigenetics; Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
O=S(NC1=NOC2=CC(CN3N=CC=C3)=C4C(OCCC4)=C21)(C5=C(OC)C=CC=C5OC)=O
Molecular Formula
C22H22N4O6S
Molecular Weight
470.50
References & Citations
[1]Zhang XM, et al. Sulfonamide derivative, preparation method therefor and medical use thereof. WO2023016484A1. 2023-02-16.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERα
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 (ICAM-3) (186-2G9), CF568 conjugate, 0.1mg/mL
CD44 Standard (156-3C11), CF647 conjugate, 0.1mg/mL
CD50 / ICAM3 (CG106), CF568 conjugate, 0.1mg/mL
